Type of Drugs for Diabetes Treatment 2: AIFA 100 - Cotidiano Sanita Information

In connection with GLP 15 recipients, DPP 4-Nimans, Double Laips 1 River and Reception Apheners

Remedies to treat -2 -diabetes mellitus: AIFA Note Update 100

To contact the SGLT recipe

18 Lug -

From July 19, 2025, SGLT2 Inhibitors, AGONISS receivers of GLP1, DPP4 inhibitors, two adapters, Agonists, GIP/GLP1 and Type 2 Diabetes are available in AIFA 100 Note.

The main changes are as follows:

- Based on DPP4 inhibition and DPP4 inhibition and DPP4.Oblifa deleting the prescription by medical medicines and medicines based medicines;

- Practitioners approved by the regions and SSN experts were prescribed by permanent or modified organizations of the drug.

The responsibility to direct the use of evaluation and photographer (message and 1b

Avoid the medication based on SGT2, Dept2, DPPTIND

The deployment of slopes in a health card system, the compilation of the evaluation and recipe form is valid.

La documentazione aggiornata sostituisce le precedenti versioni ed è disponibile sul portale AIFA nella pagina dedicata.

18 July 2025

Science reports and drugs

P.I.E C.F.13026241003

Registration and Operational Center:

Via della Stele, 23, 00186 - Rome

Via Luigi Galvani, 24, 20124 - Milan

Francesco Maria Avito

- P.I.13026241003

- Registration on ROCU number 39308

- Roman court registration N.115/3013, May 22, 2013